These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 24913302

  • 1. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
    Yousef YA, Hajja Y, Nawaiseh I, Mehyar M, Sultan I, Deebajah R, Rawashdeh K, Khurma S, Jaradat I, Al-Hussaini M.
    Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
    [Abstract] [Full Text] [Related]

  • 2. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
    Kaliki S, Shields CL, Rojanaporn D, Al-Dahmash S, McLaughlin JP, Shields JA, Eagle RC.
    Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
    [Abstract] [Full Text] [Related]

  • 3. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
    Fabian ID, Stacey AW, Chowdhury T, Duncan C, Karaa EK, Scheimberg I, Reddy MA, Sagoo MS.
    Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
    [Abstract] [Full Text] [Related]

  • 4. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.
    Kashyap S, Sethi S, Meel R, Pushker N, Sen S, Bajaj MS, Chandra M, Ghose S.
    Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967
    [Abstract] [Full Text] [Related]

  • 5. PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES.
    Yousef YA, Al-Hussaini M, Mehyar M, Sultan I, Jaradat I, AlRawashdeh K, Khurma S, Deebajah R, Nawaiseh I.
    Retina; 2015 Sep; 35(9):1883-9. PubMed ID: 25923953
    [Abstract] [Full Text] [Related]

  • 6. Clinical predictors of high risk histopathology in retinoblastoma.
    Kashyap S, Meel R, Pushker N, Sen S, Bakhshi S, Sreenivas V, Sethi S, Chawla B, Ghose S.
    Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
    [Abstract] [Full Text] [Related]

  • 7. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW.
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL.
    J Clin Oncol; 2011 Mar 01; 29(7):845-51. PubMed ID: 21282531
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
    Dikkaya F, Sarıcı AM, Erbek F, Celkan T, Mangan MS, Aydın Ö, Demirkesen C, Pazarlı H.
    Int Ophthalmol; 2018 Feb 01; 38(1):151-156. PubMed ID: 28058667
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of high-risk histopathologic features of 482 primarily enucleated retinoblastomas].
    Xu XL, Li B, Gao F, Zhang ZB.
    Zhonghua Yan Ke Za Zhi; 2018 Oct 11; 54(10):782-786. PubMed ID: 30347567
    [Abstract] [Full Text] [Related]

  • 13. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN, Feng ZX, Hazrati LN, Gallie BL, Soliman SE.
    Ophthalmology; 2019 Sep 11; 126(9):1306-1314. PubMed ID: 30986443
    [Abstract] [Full Text] [Related]

  • 14. Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.
    Wilson MW, Rodriguez-Galindo C, Billups C, Haik BG, Laningham F, Patay Z.
    Ophthalmology; 2009 Aug 11; 116(8):1558-63. PubMed ID: 19545904
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma.
    Mohammad M, Shehada R, Al-Nawaiseh I, Mehyar M, AlHussaini M, Jaradat I, Sultan I, Halalsheh H, Khzouz J, Yousef YA.
    Eur J Ophthalmol; 2023 Sep 11; 33(5):2014-2023. PubMed ID: 36760120
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug 11; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep 11; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.